Rocket Lab Slides 7% as Wider-Than-Expected Q3 Loss Overshadows Record Backlog
RKLB sits 48% above its 52-week low of $37.57.
Summary
Rocket Lab posted a Q3 GAAP loss of -$0.12 per share, missing estimates by $0.05, and shares fell about 7% in premarket trading Tuesday. Revenue was the bright spot: a record $267.8M, up 72.7% year-over-year and $10.62M above consensus. Backlog hit a record ~$3.6B, up 52%, with roughly $1B in new launch contracts signed across Electron, HASTE and Neutron, including more than $515M in Neutron contracts from constellation operators. The problem is timing: Neutron's first launch is now targeted for no earlier than 2027, a further slip from the Q4 2026 date disclosed in the 10-Q filed last night, and that pushes the key growth driver out again. Q4 guidance of $270M-$290M revenue is above the $265.42M consensus, with adjusted gross margins of 39%-41% and an adjusted EBITDA loss of $14M-$20M. The loss miss and Neutron delay are what traders are selling; the guidance and backlog are what bulls will point to.
At the time of this announcement, RKLB was trading at $55.61 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $35.2B. The 52-week trading range was $37.57 to $151.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.